Most digestive side effects are worst in the first 2-4 weeks after starting the medication or increasing the dose
The largest study to date that examines whole-genome methylation was performed as a component of the TCGA project (PTC, n = 496) [33]
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
However, if you are also taking sulfonylureas (such as gliclazide) or insulin, the risk increases significantly
Its benefits include the potential to help you avoid muscle soreness
Reordered clinics with Eden moved above Shed